NUVL – nuvalent, inc. - class a (US:NASDAQ)
Stock Stats
News
Nuvalent, Inc. (NASDAQ: NUVL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $99.00 price target on the stock.
FDA grants breakthrough therapy status for Nuvalent's NVL-655 [Yahoo! Finance]
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 [Yahoo! Finance]
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Form 4 Nuvalent, Inc. For: May 15 Filed by: Conley Emily
Form 8-K Nuvalent, Inc. For: May 16
Form SC 13G/A Nuvalent, Inc. Filed by: Flynn James E
Form 4 Nuvalent, Inc. For: May 13 Filed by: Shair Matthew
Form 10-Q Nuvalent, Inc. For: Mar 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.